...
【24h】

Fatal adverse reaction to ketorolac tromethamine in asthmatic patient.

机译:哮喘患者对酮咯酸氨丁三醇的致命不良反应。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A case of an asthmatic woman who collapsed within a few minutes after intramuscular ketorolac tromethamine (KT) injection is reported. Autopsy findings revealed anatomic evidence of a recent asthma attack. KT was found to be present in the blood at a concentration within the therapeutic range and consistent with the administered dose. Based on the timing of the collapse in relation to the KT administration, death was attributed to an adverse reaction to KT, resulting in acute bronchospasm and cardiac arrest, with asthma as an underlying contributing factor. In this case, asthma alone was not responsible for the death of the patient but only a contributing factor. Physicians have to be aware that in asthmatic patients bronchospasm can be induced by drugs among which aspirin or nonsteroidal anti-inflammatory drugs such as KT are the most common; therefore, death may have an iatrogenic cause. The paper also describes the pathogenic mechanism of an adverse reaction to such drugs and analytical methods for the isolation and detection of KT in postmortem blood.
机译:据报道,一名哮喘妇女在肌肉注射酮咯酸三甲胺(KT)后几分钟内倒下。尸检结果显示最近哮喘发作的解剖学证据。发现KT以治疗范围内的浓度存在于血液中,并与给药剂量一致。根据与服用KT有关的崩溃发生的时间,死亡归因于对KT的不良反应,导致急性支气管痉挛和心脏骤停,而哮喘是其主要诱因。在这种情况下,仅哮喘不是造成患者死亡的原因,而只是造成疾病的原因。医师必须意识到,在哮喘患者中,支气管痉挛可以由药物引起,其中阿司匹林或非甾体类抗炎药如KT最常见。因此,死亡可能是医源性原因。本文还描述了对此类药物产生不良反应的致病机理以及死后血液中KT的分离和检测的分析方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号